Skip to main content
. 2021 Jul 27;11(3):e113802. doi: 10.5812/aapm.113802

Table 1. The Results and Information of Patients in the Two Groups.

Variables Mean ± SD P-Value
Age, y 0.4
Haloperidol 36.8 ± 10.1
Dexmedetomidine 40.1 ± 15.2
Gender, % 0.7
Haloperidol
Male 53.3
Female 15
Dexmedetomidine
Male 23.3
Female 8.4
Number of days in the ICU 0.4
Haloperidol 11.8 ± 3.0
Dexmedetomidine 12.2 ± 5.2
Number of intubation days 0.1
Haloperidol 7.0 ± 3.7
Dexmedetomidine 6.3 ± 2.5